Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 1 (2024): June

Evaluation Effect of COVID -19 Vaccines on Alopecia Areata
Efek Evaluasi Vaksin COVID -19 pada Alopecia Areata



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.8931
Published
May 13, 2024

Abstract

This study investigates the impact of COVID-19 vaccination on Alopecia Areata (AA) severity, particularly focusing on gender differences. Data from 65 AA patients (30 vaccinated, 35 unvaccinated) and 1,602,596 healthy controls were analyzed. Physical examinations, laboratory tests, and Severity of Alopecia Tool (SALT) scores were used. Results showed a significant increase in AA severity among vaccinated individuals, especially males, with Pfizer's vaccine having a stronger effect post-second dose. These findings highlight the need for continued research and monitoring of AA post-COVID-19 vaccination.

 

Highlight: 

  1. Severity Rise: COVID-19 vaccination linked to increased Alopecia Areata severity, especially in males.
  2. Pfizer's Impact: Second dose shows stronger Alopecia Areata association than AstraZeneca.
  3. Continued Monitoring: Emphasizes need for ongoing research on vaccine-autoimmune disorder interactions.

 

Keyword:  Alopecia Areata, COVID-19 Vaccination, Gender Differences, Severity, Monitoring

References

  1. Strazzulla, L.C., Wang, E.H.C., Avila, L., Sicco, K.L., Brinster, N., Christiano, A.M., et al., "Alopecia Areata: Disease Characteristics, Clinical Evaluation, and New Perspectives on Pathogenesis," Journal of the American Academy of Dermatology, vol. 78, pp. 1–12, 2018.
  2. Rodriguez, T.A., Fernandes, K.E., Dresser, K.L., Duvic, M., "Concordance Rate of Alopecia Areata in Identical Twins Supports Both Genetic and Environmental Factors," Journal of the American Academy of Dermatology, vol. 62, pp. 525–7, 2010.
  3. Rajabi, F., Drake, L.A., Senna, M.M., Rezaei, N., "Alopecia Areata: A Review of Disease Pathogenesis," British Journal of Dermatology, vol. 179, pp. 1033–48, 2018.
  4. Messenger, A.G., McKillop, J., Farrant, P., McDonagh, A.J., Sladden, M., Hughes, J., et al., "British Association of Dermatologists’ Guidelines for the Management of Alopecia Areata 2012," British Journal of Dermatology, vol. 166, pp. 916–26, 2012.
  5. Jari, M.J., Abbas, G.A., Kazaal, M.A., "The Effects of Sex Hormones and Some Respiratory Diseases on the Severity of Coronavirus Infection," Bionatura, 2022.
  6. Sgubbi, P., Savoia, F., Calderoni, O., Longo, R., Stinchi, C., Tabanelli, M., "Alopecia Areata in a Patient with SARS-CoV-2 Infection," Dermatology Therapy, vol. 33, p. e14295, 2020.
  7. Fivenson, D., "COVID-19: Association with Rapidly Progressive Forms of Alopecia Areata," International Journal of Dermatology, vol. 60, p. 127, 2021.
  8. Gallo, G., Mastorino, L., Tonella, L., Ribero, S., Quaglino, P., "Alopecia Areata After COVID-19 Vaccination," Clinical and Experimental Vaccine Research, vol. 11, p. 129, 2022.
  9. Rossi, A., Magri, F., Michelini, S., Sernicola, A., Muscianese, M., Caro, G., et al., "New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations?" Journal of Cosmetic Dermatology, vol. 20, p. 2004, 2021.
  10. Kanduc, D., Shoenfeld, Y., "Molecular Mimicry Between SARS-CoV-2 Spike Glycoprotein and Mammalian Proteomes: Implications for the Vaccine," Immunological Research, vol. 68, pp. 310–3, 2020.
  11. Chu, C., Cheng, Y., Chan, J.L., "Alopecia Areata After Vaccination: Recurrence with Rechallenge," Pediatric Dermatology, vol. 33, pp. e218–9, 2016.
  12. Callaway, E., "Omicron Likely to Weaken COVID Vaccine Protection," Nature, vol. 600, pp. 367–8, 2021.
  13. Muntyanu, A., Gabrielli, S., Donovan, J., Gooderham, M., Guenther, L., Hanna, S., et al., "The Burden of Alopecia Areata: A Scoping Review Focusing on Quality of Life, Mental Health and Work Productivity," Journal of the European Academy of Dermatology and Venereology, vol. 2023.
  14. Birkett, L., Singh, P., Mosahebi, A., Dhar, S., "Possible Associations Between Alopecia Areata and COVID-19 Vaccination and Infection," Aesthetic Surgery Journal, vol. 42, pp. NP699–702, 2022.
  15. Ganjei, Z., Dana, H.F., Ebrahimi-Dehkordi, S., Alidoust, F., Bahmani, K., "Methotrexate as a Safe Immunosuppressive Agent During the COVID-19 Pandemic," International Immunopharmacology, vol. 101, p. 108324, 2021.
  16. Essam, R., Ehab, R., Al-Razzaz, R., Khater, M.W., Moustafa, E.A., "Alopecia Areata After ChAdOx1 nCoV-19 Vaccine (Oxford/AstraZeneca): A Potential Triggering Factor?" Journal of Cosmetic Dermatology, vol. 20, p. 3727, 2021.
  17. Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M.C., et al., "Recurrence of Alopecia Areata After COVID-19 Vaccination: A Report of Three Cases in Italy," Journal of Cosmetic Dermatology, vol. 20, pp. 3753–7, 2021.
  18. Bardazzi, F., Guglielmo, A., Abbenante, D., Sacchelli, L., Sechi, A., Starace, M.V.R., "New Insights into Alopecia Areata During COVID-19 Pandemic: When Infection or Vaccination Could Play a Role," Journal of Cosmetic Dermatology, vol. 21, p. 1796, 2022.
  19. May Lee, M., Bertolani, M., Pierobon, E., Lotti, T., Feliciani, C., Satolli, F., "Alopecia Areata Following COVID-19 Vaccination: Vaccine-Induced Autoimmunity?" International Journal of Dermatology, vol. 61, pp. 634–5, 2022.
  20. Gallo, G., Mastorino, L., Tonella, L., Ribero, S., Quaglino, P., "Alopecia Areata After COVID-19 Vaccination," Clinical and Experimental Vaccine Research, vol. 11, p. 129, 2022.
  21. "Coronavirus (COVID-19) Vaccines Adverse Reactions," GOV.UK, [Online]. Available: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions. [Accessed: 26-Jan-2024].
  22. "VAERS - Data," VAERS, [Online]. Available: https://vaers.hhs.gov/data.html. [Accessed: 26-Jan-2024].
  23. Alsalhi, W., Almulhim, Y., Issa, N.T., "Cross-Sectional Study to Determine the Prevalence of Telogen Effluvium Among Patients Experiencing COVID-19 Infection or Vaccination in Saudi Arabia and Arabic Countries," European Journal of Molecular and Clinical Medicine, vol. 9, pp. 4663–75, 2022.
  24. Alharbi, M., "Telogen Effluvium After COVID-19 Vaccination Among Public in Saudi Arabia," Journal of Family Medicine and Primary Care, vol. 11, p. 6056, 2022.

Downloads

Download data is not yet available.